News

Which institutions lead the field in FAIMS-MS research in 2017

Owlstone Medical commences 1,400 patient clinical trial for early detection of colorectal cancer

Owlstone Medical Announces $11.55M USD Fundraising

Owlstone Medical’s ReCIVA Named Invention of the Year in Top 50 Digital Health Awards

Medtech Insight: "Owlstone Medical is leading the charge on breath analysis"

Cambridge Business Interview with CEO Billy Boyle

Owlstone Medical Selected to Participate at Upcoming Cavendish Global Health Impact Forum

Owlstone Medical and Imperial College collaborate to study underlying causes of asthma exacerbations

Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer

Owlstone Medical commences next phase in world’s largest breath-based clinical trial for early cancer detection

Owlstone Medical strengthens management team

Owlstone Medical tipped as potential 'Unicorn' in The Spectator